{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:01:28Z","timestamp":1790557288062,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Cholangiocarcinoma has obvious primary multidrug resistance and is generally resistant to cisplatin and other chemotherapy drugs and high glycolytic levels may be associated with chemotherapy resistance of cholangiocarcinoma cells. Dichloroacetate (DCA) is a specific inhibitor of PDK, which can promote mitochondrial aerobic oxidation process by activating PDH. In the past few years, there have been an increasing number of studies supporting the action of DCA against cancer, which also provided evidence for targeting metabolism to enhance the efficacy of cholangiocarcinoma chemotherapy.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Glucose uptake and lactic acid secretion were used to detect cell metabolism level. Cell apoptosis and cell cycle were detected to confirm cell fate induced by cisplatin combined with DCA. Mito-TEMPO was used to inhibit mtROS to explore the relationship between oxidative stress and cell cycle arrest induced by DCA under cisplatin stress. Finally, PCR array and autophagy inhibitor CQ were used to explore the potential protective mechanism under cell stress.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> DCA changed the metabolic model from glycolysis to aerobic oxidation in cholangiocarcinoma cells under cisplatin stress. This metabolic reprogramming increased mitochondrial reactive oxygen species (mtROS) levels, which promoted cell cycle arrest, increased the expression of antioxidant genes and activated autophagy. Inhibition of autophagy further increased the synergistic effect of DCA and cisplatin.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> DCA increased cisplatin sensitivity in cholangiocarcinoma cells via increasing the mitochondria oxidative stress and cell growth inhibition. Synergistic effects of DCA and CQ were observed in cholangiocarcinoma cells, which further increased the cisplatin sensitivity via both metabolic reprogramming and inhibition of the stress response autophagy.<\/jats:p>","DOI":"10.3389\/fphar.2023.1128312","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T01:39:06Z","timestamp":1695692346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Hanjiao","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New insights into CDK regulators: Novel opportunities for cancer therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","article-title":"Polytherapy and targeted cancer drug resistance","volume":"5","author":"Chatterjee","year":"2019","journal-title":"Trends Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3109\/10715762.2016.1173689","article-title":"Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin-induced apoptosis in human hepatocellular carcinoma cells","volume":"50","author":"Chen","year":"2016","journal-title":"Free Radic. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1078-0432.Ccr-06-2082","article-title":"Reactive oxygen species: A breath of life or death?","volume":"13","author":"Fruehauf","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-42667-5_1","article-title":"Targeting ROS-mediated crosstalk between autophagy and apoptosis in cancer","volume":"1260","author":"Gao","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1128\/mcb.25.15.6391-6403.2005","article-title":"Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth","volume":"25","author":"Giannoni","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","article-title":"Mitochondria and the autophagy-inflammation-cell death axis in organismal aging","volume":"333","author":"Green","year":"2011","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"B11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/bmc-2016-0015","article-title":"Bcl-2 family proteins: Master regulators of cell survival","volume":"7","author":"Hatok","year":"2016","journal-title":"Biomol. Concepts"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2159-8290.Cd-20-1726","article-title":"INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"key":"B14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B15","doi-asserted-by":"publisher","first-page":"28106","DOI":"10.1074\/jbc.M803508200","article-title":"Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance","volume":"283","author":"Lu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B16","first-page":"121","article-title":"Advances in mechanisms of anti-oxidation","volume":"17","author":"Ma","year":"2014","journal-title":"Discov. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/sj.bjc.6605701","article-title":"Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells","volume":"102","author":"Madhok","year":"2010","journal-title":"Br. J. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/bst0330367","article-title":"PDH kinase inhibitors: A novel therapy for type II diabetes?","volume":"33","author":"Mayers","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"B21","doi-asserted-by":"publisher","first-page":"22700","DOI":"10.1074\/jbc.M801765200","article-title":"Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells","volume":"283","author":"McFate","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000338492","article-title":"Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: Is DCA a suitable drug for neuroblastoma therapy?","volume":"29","author":"Niewisch","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fmed.2020.00113","article-title":"Role of glucose metabolism reprogramming in the pathogenesis of cholangiocarcinoma","volume":"7","author":"Pant","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0173712","DOI":"10.1371\/journal.pone.0173712","article-title":"Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS","volume":"12","author":"Qu","year":"2017","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.18632\/oncotarget.2721","article-title":"Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: A metabolic perspective of treatment","volume":"6","author":"Ruggieri","year":"2015","journal-title":"Oncotarget"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.3892\/ol.2019.10185","article-title":"Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma","volume":"17","author":"Sanmai","year":"2019","journal-title":"Oncol. Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.molcel.2011.12.004","article-title":"Flicking the Warburg switch-tyrosine phosphorylation of pyruvate dehydrogenase kinase regulates mitochondrial activity in cancer cells","volume":"44","author":"Schulze","year":"2011","journal-title":"Mol. Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"200358","DOI":"10.1098\/rsob.200358","article-title":"Hallmarks of cancer-the new testament","volume":"11","author":"Senga","year":"2021","journal-title":"Open Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1476-4598-10-142","article-title":"Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells","volume":"10","author":"Sun","year":"2011","journal-title":"Mol. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1245\/s10434-008-0081-1","article-title":"Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma","volume":"15","author":"Tamandl","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3892\/or.2018.6275","article-title":"Metformin facilitates BG45-induced apoptosis via an anti-Warburg effect in cholangiocarcinoma cells","volume":"39","author":"Tang","year":"2018","journal-title":"Oncol. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2015.07.008","article-title":"Reactive oxygen species in redox cancer therapy","volume":"367","author":"Tong","year":"2015","journal-title":"Cancer Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.61.1588.575","article-title":"IRON, the oxygen-carrier of respiration-ferment","volume":"61","author":"Warburg","year":"1925","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell. Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/cam4.2089","article-title":"SIRT3 elicited an anti-Warburg effect through HIF1\u03b1\/PDK1\/PDHA1 to inhibit cholangiocarcinoma tumorigenesis","volume":"8","author":"Xu","year":"2019","journal-title":"Cancer Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3892\/or.2017.6153","article-title":"Survival pathway of cholangiocarcinoma via AKT\/mTOR signaling to escape RAF\/MEK\/ERK pathway inhibition by sorafenib","volume":"39","author":"Yokoi","year":"2018","journal-title":"Oncol. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.clinre.2018.01.005","article-title":"The role of ROS-induced autophagy in hepatocellular carcinoma","volume":"42","author":"Yuan","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/toxsci\/kfp101","article-title":"Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells","volume":"110","author":"Zhang","year":"2009","journal-title":"Toxicol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell. Death Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"850732","DOI":"10.3389\/fonc.2022.850732","article-title":"Overcome drug resistance in cholangiocarcinoma: New insight into mechanisms and refining the preclinical experiment models","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1128312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T01:39:10Z","timestamp":1695692350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1128312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":45,"alternative-id":["10.3389\/fphar.2023.1128312"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1128312","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"article-number":"1128312"}}